GUARANTEE & EXPIRY DATE 100% original from the Austrian Merck KGaA
Unlike full-length growth hormone, which can cause edema (fluid retention), joint pain, carpal tunnel syndrome, glucose elevation, and increased IGF-1, AOD-9604 demonstrates none of these effects in clinical trials
U40 syringes result in 2.5 times overdose
Osteogenic growth peptide (OGP) Studies have found that the naturally-occurring osteogenic growth peptide can increase bone formation and overall bone mass [5]
[9] The most frequently observed adverse reactions are mild injection-site pain, transient erythema, and localized warmth, typically resolving within minutes
Treated wounds show tightly organized mature collagen fibers with reduced myofibroblast formation[10]